Detalhe da pesquisa
1.
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia.
Cytokine
; 162: 156111, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529030
2.
Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis.
Int Arch Allergy Immunol
; 181(8): 613-617, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32570256
3.
Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study.
Clin Exp Allergy
; 54(4): 286-290, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38084474
4.
RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response.
Allergy
; 77(9): 2848-2852, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595723
5.
Association of Broad-Spectrum Antibiotic Therapy and Vitamin E Supplementation with Vitamin K Deficiency-Induced Coagulopathy: A Case Report and Narrative Review of the Literature.
J Pers Med
; 13(9)2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37763117
6.
Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality.
J Clin Med
; 12(18)2023 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762846
7.
Predictors of Mortality in Tocilizumab-Treated Severe COVID-19.
Vaccines (Basel)
; 10(6)2022 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35746585
8.
SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics.
J Allergy Clin Immunol Pract
; 10(10): 2588-2595, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752436